After a 55% rally off its March lows, the Nifty Pharma Index has confirmed a failed breakout by closing back below resistance at its early 2019 highs of 9,500. As long as prices are below that level then we'd expect some near-term weakness in this hot sector. There's a large level of support down below near 8,350, so as long as prices are above that level then any...
Pharma Giant Cipla is forming a classical Lower Top Lower Bottom Formation Looks weak to me Do ur own analysis before taking trades :)
DIVIS LAB SHORT 1850-1855 SL: 1870 TARGETS: 1824/1780/1762 ===>> TIME SPAN 1 WEEK
#NIFTYPHARMA 500 point rally possible?
#TORNTPHARM Cup and Handle Breakout @anish_sharmaaa View negated below 1595...
A long trade can be initiated around 675 levels, if Aurobindo Pharma sustains above it's resistance zone above 650, with targets close to 800 and a stop loss around 615. The Risk to reward is high, with the trade having high probabilities of success, if 675 is tested and our entry price is hit.
FOR EDUCATION / PAPER TRADING PURPOSE. Buy as per Left Shoulder support and Fibonacci confluence. With STOP below the Fib 0.
Pharma Index has been in downtrend since Dec 2017, but now it has shown some strength at 8800-8300 levels. On monthly chart index has formed bullish pattern which gives us confirmation for upside.Trade with the levels.
Weekly should signs of a reversal here